Quantcast

Latest Aspirin Stories

2014-05-01 08:37:16

Charitable Campaign Urges Women to Help Prepare for a Heart Attack by Including Bayer® Aspirin in Their Handbags WHIPPANY, N.J., May 1, 2014 /PRNewswire/ -- Each year in the U.S., nearly 300,000 women have heart attacks,(i) yet most women's handbags are better prepared to manage a broken nail (55%) or bad hair day (36%) than a heart attack (17%).(ii) Today, Bayer HealthCare, the makers of Bayer® Aspirin and WomenHeart: The National Coalition for Women with Heart Disease announce...

2014-04-24 10:48:03

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene. The extraordinary finding comes from a multi-institutional team that analyzed data and other material from two long-term studies involving nearly 128,000 participants. The researchers found that individuals whose colons have high levels of a specific gene product...

2014-04-23 23:05:26

Market Size - $239.5 mn in 2013, Market Growth - CAGR of 8.6%, Market Trends – Growing food and preservative uses of salicylic acid. View Complete Report - http://www.grandviewresearch.com/industry-analysis/salicylic-acid-market-analysis San Francisco, California (PRWEB) April 23, 2014 The global market for salicylic acid is expected to reach USD 426.8 million by 2020, according to a new study by Grand View Research, Inc. Increasing use of salicylic acid in cosmetics coupled with the...

2014-04-21 20:21:44

INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA(TM) (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, CYRAMZA becomes the first FDA-approved treatment for patients...

2014-04-09 08:28:11

Company Launches Second Innovative Offering to Accompany 'Pain Relief' Formula SEATTLE, April 9, 2014 /PRNewswire/ -- First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a great-tasting, smooth, ready-to-drink, liquid shot form, which...

Pregnant Women With High Risk For Preeclampsia Should Be On Low-Dose Aspirin Regimen: Study
2014-04-08 14:08:39

Brett Smith for redOrbit.com - Your Universe Online Marked by high blood pressure and elevated levels of protein in the urine, preeclampsia is the leading cause of death for pregnant women. New guidelines released by the US Preventative Services Task Force now recommend that pregnant women at high risk for preeclampsia take a steady low dose of aspirin as a preventative measure starting after 12 weeks of pregnancy. High-risk women include those who have a history with the condition,...

2014-04-07 13:07:48

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. However, in women with one pregnancy loss within the previous 12 months, there did appear to be a benefit. Jean Wactawski-Wende, PhD, professor in the Department of Epidemiology and Environmental Health in the School of Public Health and Health Professions at the University at Buffalo,...

2014-04-02 08:32:38

BRANFORD, Conn., April 2, 2014 /PRNewswire/ -- New Haven Pharmaceuticals, Inc. (the "Company"), a privately held specialty pharmaceuticals company, today announced the appointment of Larry Dillaha, M.D., to the newly-created position of Executive Vice President Operations. Dr. Dillaha joins the Company from Insys Therapeutics, Inc. (Nasdaq: INSY) where he served as Chief Medical Officer since April 2010. "We are delighted to welcome Larry, who will provide significant insight and...

2014-04-01 13:06:26

Bottom Line: Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen. Author: Marlies S. Reimers, M.D., Leiden University Medical Center, the Netherlands, and colleagues. Background: Prior research has suggested aspirin use after a colorectal cancer diagnosis might improve survival. Although the precise mechanism of aspirin's anti-cancer effect is unknown,...

2014-03-31 08:29:45

RARITAN, N.J., March 31, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today it is adding three new clinical trials to its EXPLORER global cardiovascular research program for XARELTO(®) (rivaroxaban), the most studied and broadly indicated oral Factor Xa inhibitor in the world today. The additional trials will evaluate rivaroxaban for the treatment or prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in pediatric and other patient...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.